PubRank

Mark A Hall

Author PubWeight™ 70.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood) 2004 3.92
2 Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med 2009 3.85
3 Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004 2.30
4 Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 2005 2.18
5 Development of a scale to measure patients' trust in health insurers. Health Serv Res 2002 1.91
6 Trust and satisfaction with physicians, insurers, and the medical profession. Med Care 2003 1.77
7 Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 2010 1.76
8 Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 2008 1.72
9 Gene selection from microarray data for cancer classification--a machine learning approach. Comput Biol Chem 2005 1.64
10 Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med 2006 1.63
11 Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol 2004 1.61
12 Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved 2007 1.58
13 In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 2004 1.58
14 How patients' trust relates to their involvement in medical care. J Fam Pract 2005 1.53
15 Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes 2010 1.50
16 Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Res 2013 1.46
17 Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med 2006 1.43
18 The impact of Blue Cross conversions on health spending and the uninsured. Health Aff (Millwood) 2005 1.41
19 Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med 2008 1.23
20 SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 2004 1.20
21 Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics 2006 1.19
22 The impact of local immigration enforcement policies on the health of immigrant hispanics/latinos in the United States. Am J Public Health 2015 1.11
23 Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. Cancer Res 2009 1.09
24 An exploration of patients' trust in physicians in training. J Health Care Poor Underserved 2004 1.07
25 Disclosure of financial relationships to participants in clinical research. N Engl J Med 2009 1.06
26 Developing model language for disclosing financial interests to potential clinical research participants. IRB 2007 1.03
27 Forests and drugs: coca-driven deforestation in tropical biodiversity hotspots. Environ Sci Technol 2011 1.03
28 Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Account Res 2007 1.03
29 Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene. Blood 2007 1.01
30 Impacts of managed care patient protection laws on health services utilization and patient satisfaction with care. Health Serv Res 2005 0.98
31 Rethinking professional ethics in the cost-sharing era. Am J Bioeth 2006 0.98
32 Myc suppression of Nfkb2 accelerates lymphomagenesis. BMC Cancer 2010 0.96
33 Impact of hemochromatosis screening in patients with indeterminate results: the hemochromatosis and iron overload screening study. Genet Med 2006 0.95
34 A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis. Blood 2006 0.94
35 Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study. Genet Test 2008 0.94
36 How patient-physician encounters in critical medical situations affect trust: results of a national survey. BMC Health Serv Res 2004 0.91
37 The essential haematopoietic transcription factor Scl is also critical for neuronal development. Eur J Neurosci 2006 0.91
38 Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J 2008 0.90
39 Evidence-based medicine on trial. JAMA 2004 0.89
40 Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings. J Gen Intern Med 2010 0.89
41 Trust in insurers and access to physicians: associated enrollee behaviors and changes over time. Health Serv Res 2004 0.87
42 Results communication and patient education after screening for possible hemochromatosis and iron overload: experience from the HEIRS Study of a large ethnically and linguistically diverse group. Genet Med 2007 0.86
43 Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med 2005 0.86
44 Insurers' responses to regulation of medical loss ratios. Issue Brief (Commonw Fund) 2012 0.86
45 Effect of language immersion on communication with Latino patients. N C Med J 2004 0.84
46 Capitation payment, length of visit, and preventive services: evidence from a national sample of outpatient physicians. Am J Manag Care 2002 0.83
47 Not so fast--jurisdictional barriers to the ACA litigation. N Engl J Med 2011 0.83
48 How Insurers Competed in the Affordable Care Act's First Year. Issue Brief (Commonw Fund) 2015 0.82
49 Insurers' use of genetic information. Jurimetrics 1996 0.81
50 Rationing health care at the bedside. N Y Univ Law Rev 1997 0.81
51 Balancing commercial and public interests. Curr Control Trials Cardiovasc Med 2004 0.79
52 Simple mixed Fe-Zn catalysts for the Suzuki couplings of tetraarylborates with benzyl halides and 2-halopyridines. Chem Commun (Camb) 2009 0.77
53 Secondary erythermalgia in an HIV-1-positive patient. AIDS Read 2003 0.76
54 What's behind health insurance rate increases? an examination of what insurers reported to the federal government in 2012-2013. Issue Brief (Commonw Fund) 2013 0.76
55 What's behind health insurance rate increases? an examination of what insurers reported to the federal government in 2013-2014. Issue Brief (Commonw Fund) 2015 0.76
56 The Affordable Care Act without the mandate. Health Aff (Millwood) 2012 0.75
57 The HIPAA headache. Hastings Cent Rep 2008 0.75
58 Conscience, Courage, and "Consent". Hastings Cent Rep 2016 0.75
59 Narrow Provider Networks for Employer Plans. EBRI Issue Brief 1 0.75
60 Swelling of the right ear. Am Fam Physician 2007 0.75
61 The Affordable Care Act survives, for now. Hastings Cent Rep 2012 0.75
62 The ethics of health care rationing. Public Aff Q 1994 0.75
63 Organ donations. Issues Sci Technol 1995 0.75
64 The patient life: can consumers direct health care? Am J Law Med 2009 0.75
65 Justice Roberts Gets It. Hastings Cent Rep 2015 0.75
66 Judicial protection of managed care consumers: an empirical study of insurance coverage disputes. Seton Hall Law Rev 1996 0.75
67 Uncombable hair syndrome. Pediatr Dermatol 2007 0.75
68 The federal medical loss ratio rule: implications for consumers in year 2. Issue Brief (Commonw Fund) 2014 0.75
69 The role of state regulation in consumer-driven health care. Am J Law Med 2005 0.75
70 Proximal white finger nails. Am Fam Physician 2004 0.75
71 The federal medical loss ratio rule: implications for consumers in year 3. Issue Brief (Commonw Fund) 2015 0.75
72 Effects of state managed care patient protection laws on physician satisfaction. Med Care Res Rev 2007 0.75
73 Disingenuous: the latest legal challenges to insurance market reforms. Hastings Cent Rep 2014 0.75
74 Do employers voluntarily include patient protections in self-insured managed care plans? Manag Care Interface 2005 0.75
75 Overbilling and informed financial consent--a contractual solution. N Engl J Med 2012 0.75
76 There oughta be a law. Hastings Cent Rep 2013 0.75
77 Health care cost containment and the stratification of malpractice law. Jurimetrics 1990 0.75